HIMX [Himax Technologies] 20-F: Indicate the number of outstanding shares of each

[Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 339,149,508 Ordinary Shares. ¨ Yes x No ¨ Yes x No x Yes ¨ No Large accelerated filer ¨ Accelerated filer x Non-accelerated filer ¨ U.S. GAAP x International Financial Reporting] [Himax Technologies, Inc. List of Subsidiaries Subsidiary Jurisdiction of Percentage of Himax Technologies Limited ROC 100.0 % Himax Technologies Korea Ltd. South Korea 100.0 % Himax Semiconductor, Inc. ROC 100.0 % Himax Technologies (Samoa), Inc. Samoa 100.0 (1) % Himax Technologies (Suzhou) Co., Ltd. PRC 100.0 (2) % Himax Technologies (Shenzhen) Co., Ltd. PRC 100.0 (2) % Himax Display, Inc.] [Certification I, Jordan Wu, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification I, Jackie Chang, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification April 30, 2013 Jordan Wu, the President and Chief Executive Officer of Himax Technologies, Inc., and Jackie Chang, the Chief Financial Officer of Himax Technologies, Inc., each certifies that, to the best of his or her knowledge: 1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and 2. the information contained] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statement (No. 333-137585 and No. 333-176863) on Form S-8 of Himax Technologies, Inc. and subsidiaries of our reports dated April 26, 2013, with respect to the consolidated balance sheets of Himax Technologies, Inc. as of December 31, 2012 and]

By | 2016-03-23T11:50:50+00:00 April 30th, 2013|Categories: Chinese Stocks, HIMX, Webplus ver|Tags: , , , , , |0 Comments

SPIL [SILICONWARE PRECISION INDUSTRIES CO] 6-K: (Original Filing)

[Contact: Siliconware Precision Industries Co., Ltd. Janet Chen, IR Director No.45, Jieh Show Rd. janet@spil.com.tw Hsinchu Science Park, Hsinchu +886-3-5795678#3675 Taiwan, 30056 Byron Chiang, Spokesperson www.spil.com.tw byronc@spil.com.tw +886-3-5795678#3671 SPIL has reached a settlement with Tessera. Issued on: April 30, 2013 Taichung, Taiwan, April 30, 2013—Siliconware Precision Industries Co., Ltd. (“SPIL”) The settlement amount of US$30 million was recognized in the]

By | 2016-03-31T08:48:45+00:00 April 30th, 2013|Categories: Chinese Stocks, SEC Original, SPIL|Tags: , , , , , |0 Comments

GIGM [GIGAMEDIA] 20-F: Page PART I 3 ITEM 1. IDENTITY OF

[Page PART I 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 21 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 35 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 61 ITEM 7. MAJOR SHAREHOLDERS AND RELATED-PARTY TRANSACTIONS 71 ITEM] [List of Subsidiaries Subsidiary* Year of Incorporation Jurisdiction of Incorporation Hoshin GigaMedia Center, Inc. 1998 Taiwan GigaMedia (HK) Limited 2004 Hong Kong GigaMedia International Holdings Limited 2004 British Virgin Islands Cambridge Entertainment Software Limited 2004 British Virgin Islands FunTown World Limited 2005 British Virgin Islands GigaMedia Online Entertainment Corp. 2009 Cayman Islands FunTown Hong Kong Limited 1999 Hong Kong GigaMedia] [EXECUTION VERSION SHARE PURCHASE AGREEMENT - among - INFOCOMM ASIA HOLDINGS PTE. LTD. - and - GIGAMEDIA ASIA PACIFIC LIMITED - and - MANAGEMENT CAPITAL INTERNATIONAL LIMITED - and - ROLAND ONG TOON WAH July 2, 2012 1 EXECUTION VERSION SHARE PURCHASE AGREEMENT Agreement This Share Purchase Agreement (this “ INFOCOMM ASIA HOLDINGS PTE. LTD. Company GIGAMEDIA ASIA PACIFIC LIMITED] [EXECUTION VERSION SHARE PURCHASE AGREEMENT - among - INFOCOMM ASIA HOLDINGS PTE. LTD. - and - GIGAMEDIA ASIA PACIFIC LIMITED - and - SPRING ASIA LIMITED - and - ROLAND ONG TOON WAH JULY 2, 2012 1 EXECUTION VERSION SHARE PURCHASE AGREEMENT Agreement Execution Date This Share Purchase Agreement (this “ INFOCOMM ASIA HOLDINGS PTE. LTD. Purchaser GIGAMEDIA ASIA PACIFIC] [Share Purchase Agreement SHARE PURCHASE AGREEMENT Agreement This SHARE PURCHASE AGREEMENT (this “ th day of August 2012 between: 1. Gigamedia Capital Limited Seller 2. Neowiz Corporation Purchaser WITNESSETH 1. Company Korea Preferred Shares WHEREAS, XL Games Inc. (the “ 2. Target Shares WHEREAS, the Seller wishes to sell to the Purchaser, and the Purchaser wishes to purchase from the] [CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER THE SARBANES-OXLEY ACT OF 2002 I, Collin Hwang, Chief Executive Officer of GigaMedia Limited, certify that: 1. I have reviewed this annual report on Form 20-F of GigaMedia Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary] [CERTIFICATION OF THE CHIEF FINANCIAL OFFICER THE SARBANES-OXLEY ACT OF 2002 I, Dirk Chen, Chief Financial Officer of GigaMedia Limited, certify that: 1. I have reviewed this annual report on Form 20-F of GigaMedia Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary] [CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Collin Hwang Chief Executive Officer 1 EX-13.1 8 d480669dex131.htm EX-13.1] [CERTIFICATION OF THE CHIEF FINANCIAL OFFICER TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dirk Chen Chief Financial Officer 1 EX-13.2 9 d480669dex132.htm EX-13.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-148663, Form S-8 No. 333-142963, Form S-8 No. 333-119616, Form S-8 No. 333-160535 and Form S-8 No. 333-168123) of GigaMedia Limited of our report dated April 30, 2013, on the consolidated financial statements and internal control over financial reporting]

SVA [SINOVAC BIOTECH] 20-F: (Original Filing)

[None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 55,091,561 common shares as of December 31, 2012 o Yes x No o Yes x No x Yes o No x Yes o No Large accelerated filer] [SINOVAC BIOTECH LTD. ARTICLE 1. PURPOSE Plan Company The purpose of the Sinovac Biotech Ltd. 2012 Share Incentive Plan (the “ ARTICLE 2. DEFINITIONS AND CONSTRUCTION Wherever the following terms are used in the Plan they shall have the meanings specified below, unless the context clearly indicates otherwise. The singular pronoun shall include the plural where the context so indicates.] [SUPPLEMENTAL AGREEMENT TO A LEASE CONTRACT Party A Lessor: China Bioway Biotech Group Co., Ltd. (hereinafter referred to as “ Party B Lessee: Sinovac Biotech Co., Ltd. (hereinafter referred to as “ Original Lease Contract WHEREAS, Party A and Party B signed a lease contract on August 12, 2004, under which Party A leased its No.2 Factory located in the] [SUPPLEMENTAL AGREEMENT TO A LEASE CONTRACT Party A Lessor: China Bioway Biotech Group Co., Ltd. (hereinafter referred to as “ Party B Lessee: Sinovac Biotech Co., Ltd. (hereinafter referred to as “ Original Lease Contract WHEREAS, Party A and Party B signed a lease contract on June 4, 2007, under which Party A leased its No.1 Factory located in the] [SUPPLEMENTAL AGREEMENT TO A LEASE CONTRACT Lessor Party A: China Bioway Biotech Group Co., Ltd. (the “ Original Lessee Party B: Sinovac Biotech Co., Ltd. (the “ New Lessee Party C: Beijing Sinovac R&D Technology Co., Ltd. (the “ Original Contract Based on the principles of equality and mutual benefit, Party A, Party B and Party C hereby enter into] [SUPPLEMENTAL AGREEMENT TO A LEASE CONTRACT Party A Lessor: China Bioway Biotech Group Co., Ltd. (hereinafter referred to as “ Party B Lessee: Beijing Sinovac R&D Technology Co., Ltd. (hereinafter referred to as “ Sinovac Beijing Original Lease Contract WHEREAS, Party A, Party B and Sinovac Biotech Co., Ltd. (hereinafter referred to as “ 1. Both parties agree that the] [List of Subsidiaries 1. Sinovac Biotech (Hong Kong) Ltd., a Hong Kong company 2. Tangshan Yian Biological Engineering Co., Ltd., a PRC company 3. Sinovac Biotech Co., Ltd., a PRC company 4. Sinovac Research and Development Co., Ltd. (formerly known as Beijing Sinovac Biological Technology Co., Ltd.), a PRC company 5. Sinovac (Dalian) Vaccine Technology Co., Ltd., a PRC company] [Certification by the Chief Executive Officer I, Weidong Yin, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Financial Officer I, Danny Chung, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Executive Officer 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.1 10 a13-4096_1ex13d1.htm EX-13.1] [Certification by the Chief Financial Officer 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.2 11 a13-4096_1ex13d2.htm EX-13.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-161827) pertaining to the 2003 Stock Option Plan of Sinovac Biotech Ltd., of our reports dated April 29, 2013, with respect to the consolidated financial statements of Sinovac Biotech Ltd. and the effectiveness of internal control over financial reporting]

By | 2016-03-24T00:44:20+00:00 April 30th, 2013|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SPIL [SILICONWARE PRECISION INDUSTRIES CO] 6-K: Contact: Siliconware Precision Industries Co., Ltd. Janet Chen,

[Contact: Siliconware Precision Industries Co., Ltd. Janet Chen, IR Director No.45, Jieh Show Rd. janet@spil.com.tw Hsinchu Science Park, Hsinchu +886-3-5795678#3675 Taiwan, 30056 Byron Chiang, Spokesperson www.spil.com.tw byronc@spil.com.tw +886-3-5795678#3671 SPIL has reached a settlement with Tessera. Issued on: April 30, 2013 Taichung, Taiwan, April 30, 2013—Siliconware Precision Industries Co., Ltd. (“SPIL”) The settlement amount of US$30 million was recognized in the]

By | 2016-03-31T08:49:53+00:00 April 30th, 2013|Categories: Chinese Stocks, SPIL, Webplus ver|Tags: , , , , , |0 Comments

SIMO [Silicon Motion Technology] 20-F: (Original Filing)

[¨ Large accelerated filer x Accelerated filer ¨ Non-accelerated filer x U.S. GAAP International Financial Reporting Standards as issued ¨ by the International Accounting Standards Board ¨ Other ¨ ¨ ¨ x PART I 1 TEM I DENTITY OF IRECTORS ENIOR ANAGEMENT AND DVISERS I 1 TEM I FFER TATISTICS AND XPECTED IMETABLE O 1 TEM I EY NFORMATION K] [Subsidiaries of Silicon Motion Technology Corporation Name of Entity Jurisdiction of Incorporation Silicon Motion Korea Ltd. Korea FCI, Inc. Korea SMI Beijing China SMI Shanghai China SMI Shenzhen China Silicon Motion K.K. Japan Silicon Motion, Inc. California Silicon Motion, Inc. Taiwan] [I, Wallace C. Kou, certify that: 1. I have reviewed this annual report on Form 20-F of Silicon Motion Technology Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [I, Riyadh Lai, certify that: 1. I have reviewed this annual report on Form 20-F of Silicon Motion Technology Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Wallace C. Kou, Chief Executive Officer Riyadh Lai, Chief Financial Officer EX-13.1 5 d480665dex131.htm EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement Nos. 333-161599, 333-142422 and 333-131219 on Forms S-8 of our reports dated April 29, 2013, relating to (1) the consolidated financial statements of Silicon Motion Technology Corporation and subsidiaries (the “Company”) (which report expresses an unqualified opinion and includes an explanatory paragraph relating]

By | 2016-03-14T18:48:26+00:00 April 30th, 2013|Categories: Chinese Stocks, SEC Original, SIMO|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 20-F: None (Title of Class) Indicate the number of

[None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 55,091,561 common shares as of December 31, 2012 o Yes x No o Yes x No x Yes o No x Yes o No Large accelerated filer] [SINOVAC BIOTECH LTD. ARTICLE 1. PURPOSE Plan Company The purpose of the Sinovac Biotech Ltd. 2012 Share Incentive Plan (the “ ARTICLE 2. DEFINITIONS AND CONSTRUCTION Wherever the following terms are used in the Plan they shall have the meanings specified below, unless the context clearly indicates otherwise. The singular pronoun shall include the plural where the context so indicates.] [SUPPLEMENTAL AGREEMENT TO A LEASE CONTRACT Party A Lessor: China Bioway Biotech Group Co., Ltd. (hereinafter referred to as “ Party B Lessee: Sinovac Biotech Co., Ltd. (hereinafter referred to as “ Original Lease Contract WHEREAS, Party A and Party B signed a lease contract on August 12, 2004, under which Party A leased its No.2 Factory located in the] [SUPPLEMENTAL AGREEMENT TO A LEASE CONTRACT Party A Lessor: China Bioway Biotech Group Co., Ltd. (hereinafter referred to as “ Party B Lessee: Sinovac Biotech Co., Ltd. (hereinafter referred to as “ Original Lease Contract WHEREAS, Party A and Party B signed a lease contract on June 4, 2007, under which Party A leased its No.1 Factory located in the] [SUPPLEMENTAL AGREEMENT TO A LEASE CONTRACT Lessor Party A: China Bioway Biotech Group Co., Ltd. (the “ Original Lessee Party B: Sinovac Biotech Co., Ltd. (the “ New Lessee Party C: Beijing Sinovac R&D Technology Co., Ltd. (the “ Original Contract Based on the principles of equality and mutual benefit, Party A, Party B and Party C hereby enter into] [SUPPLEMENTAL AGREEMENT TO A LEASE CONTRACT Party A Lessor: China Bioway Biotech Group Co., Ltd. (hereinafter referred to as “ Party B Lessee: Beijing Sinovac R&D Technology Co., Ltd. (hereinafter referred to as “ Sinovac Beijing Original Lease Contract WHEREAS, Party A, Party B and Sinovac Biotech Co., Ltd. (hereinafter referred to as “ 1. Both parties agree that the] [List of Subsidiaries 1. Sinovac Biotech (Hong Kong) Ltd., a Hong Kong company 2. Tangshan Yian Biological Engineering Co., Ltd., a PRC company 3. Sinovac Biotech Co., Ltd., a PRC company 4. Sinovac Research and Development Co., Ltd. (formerly known as Beijing Sinovac Biological Technology Co., Ltd.), a PRC company 5. Sinovac (Dalian) Vaccine Technology Co., Ltd., a PRC company] [Certification by the Chief Executive Officer I, Weidong Yin, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Financial Officer I, Danny Chung, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Executive Officer 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.1 10 a13-4096_1ex13d1.htm EX-13.1] [Certification by the Chief Financial Officer 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.2 11 a13-4096_1ex13d2.htm EX-13.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-161827) pertaining to the 2003 Stock Option Plan of Sinovac Biotech Ltd., of our reports dated April 29, 2013, with respect to the consolidated financial statements of Sinovac Biotech Ltd. and the effectiveness of internal control over financial reporting]

By | 2016-03-24T00:45:22+00:00 April 30th, 2013|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

VIMC [Vimicro International] 20-F: (Original Filing)

[FORM 20-F (Mark One) o OR x OR o For the transition period from to OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . VIMICRO INTERNATIONAL CORPORATION N/A Cayman Islands (Jurisdiction of incorporation or organization) 15/F Shining Tower No. 35] [Shanxi Guoxin Investment (Group) Corporation Vimicro Corporation Beijing Zhongxing Tianshi Consulting Company Investment Agreement Regarding the Establishment of Zhongtianxin Science and Technology Co., Ltd. July 13, 2012 Agreement China This Investment Agreement (this “ (1) Guoxin Group Shanxi Guoxin Investment (Group) Corporation (“ (2) Vimicro China Beijing Vimicro Corporation (“ (3) VMF Consulting Company Beijing Zhongxing Tianshi Consulting Company (“] [Nominee Agreement The Nominee Agreement (the “Agreement”) is signed by the following two parties on July 12, 2012 in Beijing. Party A: Vimicro Corporation ( Principal the “ Address: 15/F, Shining Tower, No.35, Xueyuan Road, Haidian District, Beijing, China Legal Representative: Zhonghan Deng Nominee Party B: Vimicro Zhongxing Tianshi Consulting Company (the “ Address: Room 1612, Shining Tower, No.35, Xueyuan] [EXECUTION COPY ASSIGNMENT AND ASSUMPTION AGREEMENT Agreement GAP LP GAP-W GAP Coinvestments III GAP Coinvestments IV GapStar Assignor Assignors Assignee Company THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (this “ Registration Rights Agreement Capitalized terms used and not otherwise defined herein will have the respective meanings ascribed to such terms in the Registration Rights Agreement (the “ WHERAS, the Assignors and the] [SHARE TRANSFER AGREEMENT This share transfer agreement is made in Shanghai, China on this day of August 2, 2012 by and between: (1) Vimicro International Corporation, a corporation established and existing under the laws of Cayman Islands, with its registered address at P.O. BoX 209GT, Ugland House South Church Street, George Town, Grand Cayman, Cayman Island (hereinafter referred to as] [SHARE TRANSFER AGREEMENT This share transfer agreement is made in Shenzhen, China on this day of April 26, 2013 by and between: (1) Vimicro International Corporation, a corporation established and existing under the laws of Cayman Islands, with its registered address at P.O. BoX 209GT, Ugland House South Church Street, George Town, Grand Cayman, Cayman Island (hereinafter referred to as] [SETTLEMENT AGREEMENT THIS SETTLEMENT AGREEMENT (“Settlement Agreement”) is entered into between Vimicro Corporation (hereinafter the “ Creditor ”), and Qingdao Vimicro Corporation (hereinafter the “ Debtor ”) on April 26, 2013 . Creditor and Debtor individually shall be referred as “Party” and collectively shall be referred as “Parties.” REC ITALS A. On December 26, 2011, the Debtor and the Creditor] [List of Subsidiaries as of December 31, 2012 Our Subsidiaries · Vimicro Corporation, incorporated in the People’s Republic of China · Vimicro Technology Corporation, incorporated in the People’s Republic of China · Viewtel Corporation, incorporated in California, U.S.A. · Vimicro Electronics International Limited, incorporated in Hong Kong Special Administrative Region · Vimicro Electronic Technology Corporation, incorporated in the People’s Republic] [CERTIFICATIONS I, Zhonghan (John) Deng, certify that: 1. I have reviewed this annual report on Form 20-F of Vimicro International Corporation (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATIONS I, Jinming (Jimmy) Dong , certify that: 1. I have reviewed this annual report on Form 20-F of Vimicro International Corporation (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 30, 2013 EX-13.1 11 a13-5457_1ex13d1.htm EX-13.1] [CERTIFICATIONS Jinming (Jimmy) Dong (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 30, 2013 Jinming (Jimmy) Dong Jinming (Jimmy) Dong EX-13.2 12 a13-5457_1ex13d2.htm EX-13.2] [Our ref GDK/605073/6055734v1 Direct tel +852 3690 7444 E-mail jack.huang@maplesandcalder.com Vimicro International Corporation 15/F Shining Tower No. 35 Xueyuan Road Haidian District Beijing 100191 People’s Republic of China 30 April 2013 Dear Sir Re: Vimicro International Corporation Company Form 20-F We have acted as legal advisors as to the laws of the Cayman Islands to Vimicro International Corporation, an exempted] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the following Registration Statements: (1) Registration Statement (Form S-8 No. 333-135914) of the 2004 Share Option Plan and 2005 Share Incentive Plan of Vimicro International Corporation, (2) Registration Statement (Form S-8 No. 333-166829) of the 2005 Share Incentive Plan of Vimicro International Corporation, and (3)]

By | 2016-03-31T18:15:30+00:00 April 30th, 2013|Categories: Chinese Stocks, SEC Original, VIMC|Tags: , , , , , |0 Comments

JKS [JinkoSolar] 20-F: (Original Filing)

[TABLE OFNTENTS Page INTRODUCTION 1 PART I 2 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 2 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 2 ITEM 3. KEY INFORMATION 2 ITEM 4. INFORMATION ON THEMPANY 35 ITEM 4A. UNRESOLVED STAFFMMENTS 55 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS] [Subsidiarieste oforporation /Acquisition Place oforporation Percentage of Ownership Paker JinkoSolar Technology Limited ( November 10, 2006 Hong Kong 100% JinkoSolar International JinkoSolar International Limited ( November 25, 2009 Hong Kong 100% Jiangxi Jinko Jinko Solar ( December 13, 2006 100% Jinko Import and Export Jinko Solar Import and Export ("] [I, Kangping Chen, certify that: 1. I have reviewed this annual report on Form 20-F of JinkoSolar; 2. Based on my knowledge, this annual report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [I, Longgen Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of JinkoSolar; 2. Based on my knowledge, this annual report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [1 2 The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. v342779_ex13-1.htm 5 EX-13.1] [1 2 The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. v342779_ex13-2.htm 6 EX-13.2] [April 30, 2013 100 F Street, N.E.mmissioners:ted April 30, 2013. Weree with the statementsncerning our Firm in Item 16F(a)(1) in such Form 20-F. We have read the statements made by JinkoSolar , Very truly yours, PricewaterhouseCoopers Zhong Tian CPAs Limitedmpany Shanghai, Peoples Republic of China] [April 30, 2013 Ladies and Gentlemen: We have read Shanghai, the Peoples Republic of China v342779_ex15-2.htm 8 EX-15.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on Form S-8 (No. 333-180787) of JinkoSolar of our reportted April 30, 2013 relating to thensolidated financial statements, which appears in this Form 20-F. PricewaterhouseCoopers Zhong Tian CPAs Limitedmpany]

By | 2016-02-04T13:07:24+00:00 April 30th, 2013|Categories: Chinese Stocks, JKS, SEC Original|Tags: , , , , , |0 Comments

SIMO [Silicon Motion Technology] 20-F: ¨ Large accelerated filer x Accelerated filer ¨

[¨ Large accelerated filer x Accelerated filer ¨ Non-accelerated filer x U.S. GAAP International Financial Reporting Standards as issued ¨ by the International Accounting Standards Board ¨ Other ¨ ¨ ¨ x PART I 1 TEM I DENTITY OF IRECTORS ENIOR ANAGEMENT AND DVISERS I 1 TEM I FFER TATISTICS AND XPECTED IMETABLE O 1 TEM I EY NFORMATION K] [Subsidiaries of Silicon Motion Technology Corporation Name of Entity Jurisdiction of Incorporation Silicon Motion Korea Ltd. Korea FCI, Inc. Korea SMI Beijing China SMI Shanghai China SMI Shenzhen China Silicon Motion K.K. Japan Silicon Motion, Inc. California Silicon Motion, Inc. Taiwan] [I, Wallace C. Kou, certify that: 1. I have reviewed this annual report on Form 20-F of Silicon Motion Technology Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [I, Riyadh Lai, certify that: 1. I have reviewed this annual report on Form 20-F of Silicon Motion Technology Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Wallace C. Kou, Chief Executive Officer Riyadh Lai, Chief Financial Officer EX-13.1 5 d480665dex131.htm EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement Nos. 333-161599, 333-142422 and 333-131219 on Forms S-8 of our reports dated April 29, 2013, relating to (1) the consolidated financial statements of Silicon Motion Technology Corporation and subsidiaries (the “Company”) (which report expresses an unqualified opinion and includes an explanatory paragraph relating]

By | 2016-03-14T18:49:33+00:00 April 30th, 2013|Categories: Chinese Stocks, SIMO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar